Complement system and suicidal behavior
补体系统与自杀行为
基本信息
- 批准号:9892445
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAntidepressive AgentsAreaAttenuatedAutopsyBehaviorBehavioral ParadigmBone MarrowBrainCessation of lifeChimera organismChronicChronic stressClassical Complement PathwayComplementComplement 3Complement ActivationComplement Factor HComplement InactivatorsConfounding Factors (Epidemiology)DataDepressed moodDiagnosisDiseaseExposure toFeeling suicidalFunctional disorderGeneral PopulationGoalsHumanImmuneImmune systemImmunityImpulsivityIndividualInfiltrationInflammationInflammatoryLearned HelplessnessLectinMeasuresMediatingMental DepressionMental disordersMessenger RNAMicrogliaMilitary PersonnelModelingMusMyeloid CellsPathway interactionsPeripheralPharmaceutical PreparationsPre-Clinical ModelPrefrontal CortexProteinsPublishingRecording of previous eventsRegulationReportingRisk FactorsRoleStressSubstance of AbuseSuicideTherapeuticTherapeutic AgentsUnited StatesVeteransWaraccomplished suicideadaptive immune responsearmbrain behaviorbrain tissuecomplement pathwaycomplement systemcytokinedepressive symptomsdesignexperimental studyknockout genemonocytemouse modelnew therapeutic targetnovelnovel therapeuticspreventrecruitsuicidal behaviorsuicidal risksuicide brainsuicide ratetrauma exposure
项目摘要
Approximately 800,000 people die from suicide each year and the recent data show that the suicide rate in the
United States has increased 33% from 1999 to 2017. United States military veterans have an increased risk of
suicide compared with the general population, and approximately 18 to 22 veterans die from suicide each day.
It has been reported that up to 90% of individuals who complete suicide have an underlying psychiatric
disorder. Suicidal ideation in war veterans is often associated with post-traumatic disorder (PTSD) or
depression, conditions that often coexist. In addition, as a fundamental factor in the provocation of depression,
chronic stress is associated with suicidal thoughts and behaviors. Also, a history of prior exposure to trauma or
to chronic stress is an extremely potent risk factor for PTSD. In preclinical models, chronic stress has been
shown to induce changes in behavioral paradigms that can be used to measure aspects of suicidal behavior
such as impulsive, aggressive, and depressive-like behaviors. Recent evidence indicate that inflammation, as
manifested by increased levels of pro‐inflammatory cytokines, contributes to the pathophysiology of suicidality.
However, there is a critical need for studies that are designed to determine the role of specific components of
the immune system in suicidal behavior in order to identify novel therapeutic targets. The complement system
is part of the innate arm of immunity, but also regulates many aspects of the adaptive immune response.
Complement can be activated via the classical, lectin or alternative pathway with complement component 3
(C3) as the converging point of the activation pathways. Our recent study showed an important role of C3 in
chronic stress-induced depressive-like behavior in mice. However, it is not known whether chronic stress-
induced complement activation mediates suicidal behavior. We hypothesize that classical pathway mediates
stress-induced complement activation leading to suicidal behavior. In supporting this, our published and
preliminary studies found that (1) C3 and C1qa (a key component of classical pathway) are highly expressed in
the prefrontal cortex (PFC) of depressed suicide subjects; 2) exposure to chronic stress conditions induces
increases in C1qa and C3 protein levels in mouse PFC; and (3) inhibition of C3 by gene knockout (C3 KO)
significantly ameliorated chronic stress-induced aggressive and depressive-like behavior, and infiltration of
monocytes into mouse PFC. To further understand the role of complement activation in suicidal behavior, we
propose the three Specific Aims to 1) determine the role of complement activation pathway in suicide (with
depression or PTSD diagnosis) subjects; 2) investigate whether complement classical pathway is critical to
stress-induced suicidal behavior; and 3) determine whether central complement system mediates stress-
induced suicidal behavior. Given the important role of immune pathways in suicidal behavior, identifying novel
regulatory mechanisms may provide avenues to develop newer therapeutics for suicidal behavior.
每年约有80万人死于自杀,最近的数据显示,
美国从1999年到2017年增加了33%。美国退伍军人的风险增加
与一般人口相比,自杀率较高,每天约有 18 至 22 名退伍军人死于自杀。
据报道,高达 90% 的自杀者有潜在的精神疾病
战争退伍军人的自杀意念通常与创伤后精神障碍(PTSD)或
抑郁症,这些情况经常并存 此外,作为引发抑郁症的基本因素,
慢性压力也与自杀念头和行为有关。此外,之前有过创伤或经历。
在临床前模型中,慢性压力是 PTSD 的一个极其有效的危险因素。
被证明会引起行为范式的变化,可用于衡量自杀行为的各个方面
最近的证据表明,炎症与冲动、攻击性和抑郁样行为有关。
表现为促炎细胞因子水平增加,导致自杀的病理生理学。
然而,迫切需要进行旨在确定特定成分的作用的研究。
自杀行为中的免疫系统,以确定新的治疗靶点。
是先天免疫的一部分,但也调节适应性免疫反应的许多方面。
补体可以通过经典、凝集素或补体成分 3 的替代途径被激活
(C3) 作为激活途径的汇聚点,我们最近的研究表明 C3 在激活途径中发挥着重要作用。
然而,尚不清楚慢性压力是否会导致小鼠出现抑郁样行为。
诱导激活补体介导自杀行为。我们勇敢地承认经典途径介导。
压力诱导的补体激活会导致自杀行为。
初步研究发现(1)C3和C1qa(经典途径的关键组成部分)在
2)暴露于慢性压力条件下会导致抑郁症自杀者的前额皮质(PFC);
小鼠 PFC 中 C1qa 和 C3 蛋白水平增加;(3) 通过基因敲除 (C3 KO) 抑制 C3
显着改善慢性压力诱发的攻击性和抑郁样行为,以及
为了进一步了解补体激活在自杀行为中的作用,我们
提出三个具体目标 1) 确定补体激活途径在自杀中的作用(
2) 研究补体经典途径是否至关重要
压力诱发的自杀行为;以及3)确定中枢补体系统是否介导压力-
鉴于免疫途径在自杀行为中的重要作用,识别新的自杀行为。
监管机制可能为开发针对自杀行为的新疗法提供途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anilkumar Pillai其他文献
Anilkumar Pillai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anilkumar Pillai', 18)}}的其他基金
Mitochondrial DNA, chronic stress, and inflammation
线粒体 DNA、慢性压力和炎症
- 批准号:
10664066 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Complement Component, Neuroinflammation and Depression
补体成分、神经炎症和抑郁症
- 批准号:
10462803 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Complement component, neuroinflammation and depression
补体成分、神经炎症和抑郁症
- 批准号:
9914544 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Chronic stress, complement immune system and behavior
慢性压力、补体免疫系统和行为
- 批准号:
9905204 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Complement Component, Neuroinflammation and Depression
补体成分、神经炎症和抑郁症
- 批准号:
10670822 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Complement Component, Neuroinflammation and Depression
补体成分、神经炎症和抑郁症
- 批准号:
10402977 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Chronic stress, complement immune system and behavior
慢性压力、补体免疫系统和行为
- 批准号:
10396335 - 财政年份:2019
- 资助金额:
-- - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
脆性X综合征动物模型中异常视觉信息处理和视觉注意力的神经环路机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
N-acetylserotonin alleviates neurotoxicity in alcohol misuse following TBI
N-乙酰血清素可减轻 TBI 后酒精滥用造成的神经毒性
- 批准号:
10591834 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Neural activity and circuitry-mediated hippocampal stress responses
神经活动和电路介导的海马应激反应
- 批准号:
10903002 - 财政年份:2023
- 资助金额:
-- - 项目类别:
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.
体内靶向神经活性类固醇和免疫网络治疗艾滋病毒感染者的抑郁症。
- 批准号:
10535147 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Role of TNFalpha in discogenic pain progression and as a treatment target
TNFα 在椎间盘源性疼痛进展中的作用及其作为治疗靶点
- 批准号:
10375766 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Role of TNFalpha in discogenic pain progression and as a treatment target
TNFα 在椎间盘源性疼痛进展中的作用及其作为治疗靶点
- 批准号:
10755462 - 财政年份:2022
- 资助金额:
-- - 项目类别: